INTEGRAL MOLECULAR Trademark

Trademark Overview

On Friday, January 4, 2002, a trademark application was filed for INTEGRAL MOLECULAR with the United States Patent and Trademark Office. The USPTO has given the INTEGRAL MOLECULAR trademark a serial number of 76355744. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, January 17, 2023. This trademark is owned by Integral Molecular, Inc.. The INTEGRAL MOLECULAR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Drug discovery and development services for the biotechnology and pharmaceutical industries
integral molecular

General Information

Serial Number76355744
Word MarkINTEGRAL MOLECULAR
Filing DateFriday, January 4, 2002
Status800 - REGISTERED AND RENEWED
Status DateTuesday, January 17, 2023
Registration Number2691636
Registration DateTuesday, February 25, 2003
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 11, 2002

Trademark Statements

Goods and ServicesDrug discovery and development services for the biotechnology and pharmaceutical industries

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 16, 2002
Primary Code042
First Use Anywhere DateThursday, December 20, 2001
First Use In Commerce DateThursday, December 20, 2001

Trademark Owner History

Party NameIntegral Molecular, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104-564
Party NameIntegral Molecular, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104
Party NameIntegral Molecular, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19104

Trademark Events

Event DateEvent Description
Wednesday, March 13, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 13, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 13, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 13, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 13, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 17, 2024WITHDRAWAL OF ATTORNEY GRANTED
Wednesday, January 17, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Tuesday, January 17, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, January 17, 2023REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Tuesday, January 17, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, January 14, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 29, 2022TEAS SECTION 8 & 9 RECEIVED
Friday, February 25, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, May 3, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, May 3, 2012REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, May 3, 2012REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, May 3, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, April 13, 2012TEAS SECTION 8 & 9 RECEIVED
Wednesday, July 23, 2008REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, July 9, 2008ASSIGNED TO PARALEGAL
Thursday, June 26, 2008TEAS SECTION 8 & 15 RECEIVED
Friday, June 27, 2008CASE FILE IN TICRS
Tuesday, February 25, 2003REGISTERED-PRINCIPAL REGISTER
Friday, December 20, 2002ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, December 18, 2002ASSIGNED TO EXAMINER
Thursday, December 12, 2002STATEMENT OF USE PROCESSING COMPLETE
Friday, October 11, 2002USE AMENDMENT FILED
Tuesday, October 15, 2002PAPER RECEIVED
Tuesday, September 3, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 11, 2002PUBLISHED FOR OPPOSITION
Wednesday, May 22, 2002NOTICE OF PUBLICATION
Sunday, March 24, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 22, 2002ASSIGNED TO EXAMINER

Related Keywords

molecular integral pharmaceutical industries biotechnology services discovery development drug